DT
MYGN icon

Diversified Trust’s Myriad Genetics MYGN Stock Holding History

Diversified Trust’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$327K Buy
+8,390
New +$312K 0.03% 452
2013
Q3 		– Sell
-14,270
Closed -$384K – 474
2013
Q2 		$384K Buy
+14,270
New +$414K 0.05% 353

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Diversified Trust's MYGN Position: Q2 2014 in Review

Diversified Trust opened a new position in Myriad Genetics (MYGN) in Q2 2014: 8,390 shares worth $327K. The stake represents 0.03% of the portfolio and ranks #452 among its holdings. This is a return to the name: Diversified Trust previously reported a position in MYGN as recently as Q2 2013.

Diversified Trust first reported a position in MYGN in Q2 2013 and has held it in 2 quarters since. The position peaked at $384K in Q2 2013. 283 funds tracked by Wall St. Rank hold MYGN as of Q2 2014.

  • Diversified Trust held 8,390 shares of Myriad Genetics worth $327K as of Q2 2014.
  • Myriad Genetics was a new Diversified Trust position in Q2 2014.
  • Myriad Genetics made up 0.03% of Diversified Trust's portfolio in Q2 2014, its #452 holding.
  • Diversified Trust first reported a position in Myriad Genetics in Q2 2013 and has held it in 2 quarters since.
  • Diversified Trust's Myriad Genetics position peaked at $384K in Q2 2013.
  • 283 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2014.

Based on Diversified Trust's 13F filing for Q2 2014, filed 15 Aug 2014.